Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals consuming pomegranate: A randomized clinical trial

González‐Sarrías, Antonio, García‐Villalba, Rocío, Romo‐Vaquero, María, Alasalvar, Cesarettin, Örem, Asim, Zafrilla, Pilar, Tomás‐Barberán, Francisco A., Selma, María V., Espín, Juan Carlos · 2017 · Molecular Nutrition & Food Research

Abstract

Scope: The pomegranate lipid‐lowering properties remain controversial, probably due to the interindividual variability in polyphenol (ellagitannins) metabolism. Objective: We aimed at investigating whether the microbially derived ellagitannin‐metabolizing phenotypes, i.e. urolithin metabotypes A, (UM‐A), B (UM‐B), and 0 (UM‐0), influence the effects of pomegranate extract (PE) consumption on 18 cardiovascular risk biomarkers in healthy overweight‐obese individuals. Methods and results: A double‐blind, crossover, dose–response, randomized, placebo‐controlled trial was conducted. The study (POMEcardio) consisted of two test phases (dose‐1 and dose‐2, lasting 3 weeks each) and a 3‐week washout period between each phase. Forty‐nine participants (BMI > 27 kg/m 2) daily consumed one (dose‐1, 160 mg phenolics/day) or four (dose‐2, 640 mg phenolics/day) PE or placebo capsules. Notably, UM‐B individuals showed the highest baseline cardiovascular risk. After dose‐2, total cholesterol (–15.5 ± 3.7%), LDL‐cholesterol (–14.9 ± 2.1%), small LDL‐cholesterol (–47 ± 7%), non‐HDL‐cholesterol (–11.3 ± 2.5%), apolipoprotein‐B (–12 ± 2.2%), and oxidized LDL‐cholesterol –24 ± 2.5%) dose dependently decreased (P < 0.05) but only in UM‐B subjects. These effects were partially correlated with urolithin production and the increase in Gordonibacter levels. Three (50%) nonproducers (UM‐0) became producers following PE consumption. Conclusions: UM clustering suggests a personalized effect of ellagitannin‐containing foods and could explain the controversial pomegranate benefits. Research on the specific role of urolithins and the microbiota associated with each UM is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mnfr.201600830

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 48

  1. Kim S. H., 2015, Obesity and cardiovascular disease: friend or foe?, Eur. Heart J.
  2. 10.1016/j.cmet.2013.05.009 · DOI
  3. Jain K. K., 2002, Personalized medicine, Curr. Opin. Mol. Ther., 4, 548
  4. 10.1079/BJN20051565 · DOI
  5. 10.1038/ejcn.2014.23 · DOI
  6. 10.1002/ptr.5280 · DOI
  7. 10.1002/mnfr.201500227 · DOI
  8. 10.1016/j.nutres.2014.08.003 · DOI
  9. 10.5812/ijem.33835 · DOI
  10. Kojadinovic M. I., 2016, Pomegranate juice consumption decrease blood lipid peroxidation and level of arachidonic acid in women with metabolic syndrome, J. Sci. Food Agric.
  11. 10.1016/j.phymed.2015.12.014 · DOI
  12. 10.1016/j.copbio.2012.09.009 · DOI · Paper page
  13. 10.1021/jf5024615 · DOI · Paper page
  14. 10.1002/mnfr.201600557 · DOI · Paper page
  15. Tomás‐Barberán F. A., 2016, Urolithins, the rescue of 'old' metabolites to understand a 'new' concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and host health status, Mol. Nutr. Food Res.
  16. 10.1039/C5FO01100K · DOI
  17. 10.1016/j.chroma.2015.08.044 · DOI
  18. 10.1021/acs.jafc.5b02062 · DOI
  19. 10.3945/jn.109.112912 · DOI
  20. 10.1007/s11130-012-0325-x · DOI
  21. 10.1002/mnfr.201100673 · DOI · Paper page
  22. 10.1186/1743-7075-6-41 · DOI
  23. 10.1016/S0002-9149(03)00111-5 · DOI
  24. 10.1111/j.1574-6941.2009.00671.x · DOI · Paper page
  25. 10.1016/j.jff.2015.06.040 · DOI
  26. 10.1038/520609a · DOI · Paper page
  27. 10.1002/mnfr.201100531 · DOI
  28. 10.1002/mnfr.201100513 · DOI
  29. 10.1016/j.freeradbiomed.2013.05.046 · DOI · Paper page
  30. 10.1097/MCO.0000000000000314 · DOI · Paper page
  31. 10.1002/mnfr.201500940 · DOI
  32. 10.2174/13816128113199990407 · DOI · Paper page
  33. 10.1002/mnfr.201400866 · DOI
  34. 10.1002/mnfr.201400390 · DOI
  35. 10.1002/mnfr.201500091 · DOI
  36. 10.3945/ajcn.115.125690 · DOI
  37. EFSA. Scientific Opinion on the substantiation of health claims related to pomegranate/pomegranate juice and maintenance of normal blood cholesterol concentrations (ID 1162 1320 2107 2167) maintenance of normal erectile function (ID 1163) protection of lipids from oxidative damage (ID 1201 1319 2123) “antioxidant and anti‐aging properties” (ID 1901) increase in appetite after unintentional weight loss leading to an increase in energy intake (ID 2122) and maintenance of normal blood glucose concentrations (ID 4471) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.EFSA J. 2010 8 1750 [22 pp.]. · doi:10.2903/j.efsa.2010.1750
  38. EFSA. Scientific opinion on the substantiation of a health claim related to a combination of pomegranate pomace extract and greater galangal rhizome powder and an increase in the number of motile spermatozoa in semen pursuant to Article 13(5) of Regulation (EC) No 1924/2006.EFSA J. 2015 13 4097 [16 pp.]. · DOI
  39. 10.1016/S0140-6736(11)60105-0 · DOI · Paper page
  40. Frankenfeld C. L., 2016, Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes, Mol. Nutr. Food Res
  41. Reverri E. J., 2016, Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors, Mol. Nutr. Food Res.
  42. 10.1021/jf049144d · DOI · Paper page
  43. 10.1016/j.jnutbio.2009.04.012 · DOI · Paper page
  44. 10.1016/j.bmcl.2011.07.086 · DOI
  45. 10.1002/mnfr.201500357 · DOI
  46. 10.1016/j.ijfoodmicro.2010.03.038 · DOI · Paper page
  47. 10.1039/C5FO00669D · DOI
  48. 10.1046/j.1365-2796.2002.01054.x · DOI

Cited by

See all 230

Metadata

Authors
González‐Sarrías, A., García‐Villalba, R., Romo‐Vaquero, M., Alasalvar, C., Örem, A., Zafrilla, P., Tomás‐Barberán, F. A., Selma, M. V., & Espín, J. C.
Venue
Molecular Nutrition & Food Research
Publisher
Wiley
Published
2017-05
Volume
61
Issue
5
ISSN
  • 1613-4125 (ISSN-L)
  • 1613-4133
OpenAlex
W2553070638
Cited by
230
References
5
FWCI
18.74
Type
journal article
Language
en
Open access
closed
Funders
  • Ministerio de Economía y Competitividad (201370E068)
  • Comisión Sectorial de Investigación Científica

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals consuming pomegranate: A randomized clinical trial. https://app.cochat.ai/papers/10.1002/mnfr.201600830
The paper
González‐Sarrías, A., García‐Villalba, R., Romo‐Vaquero, M., Alasalvar, C., Örem, A., Zafrilla, P., Tomás‐Barberán, F. A., Selma, M. V., & Espín, J. C. (2017). Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals consuming pomegranate: A randomized clinical trial. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.201600830

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.